Companies / Eledon Pharmaceuticals, Inc. / Activity
Activity — Eledon Pharmaceuticals, Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common stock | $302.0K | +77K | 76,643 0.10% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | New | Common stock | $288.4K | +70K | 70,000 0.09% of shares | low |
| Q1 2026 as of | Baker Ellis Asset Management LLC 13F manager | New | Common stock | $58.5K | +19K | 19,000 0.02% of shares | low |
| Q2 2026 as of | WINTON GROUP Ltd 13F manager | New | Common stock | $50.8K | +13K | 12,900 0.02% of shares | low |
| Q1 2026 as of | Prudential Financial Inc 13F manager | New | Common stock | $32.2K | +10K | 10,450 0.01% of shares | low |
| Q1 2026 as of | Grandfield & Dodd, LLC 13F manager | New | Common stock | $30.8K | +10K | 10,000 0.01% of shares | low |
| Q2 2026 as of | IMG Wealth Management, Inc. 13F manager | New | Common stock | $1.4K | +352 | 352 <0.01% of shares | low |
| Q1 2026 as of | MAI Capital Management 13F manager | New | Common stock | $410 | +133 | 133 <0.01% of shares | low |
| Q1 2026 as of | Pittenger & Anderson Inc 13F manager | New | Common stock | $108 | +35 | 35 <0.01% of shares | low |